March 18, 2016

Regenerative Medicine Minnesota Announces 2016 Research Award Recipients

By lmulvihill

Regenerative Medicine Minnesota is a state supported initiative to advance Regenerative Medicine. 

Mayo Clinic awardees include:

  • Dr. John C. Burnett, Jr, MD     (Translational Research Grant)  Novel Cell-Free Peptide Therapeutics for Cardiac Repair and Regeneration.  Dr. Burnett's study will focus on the use of Mayo Clinic-engineered peptides in cardiac repair and regeneration.
  • Dr. Kimberly Holst, MD      (Clinical Trial Grant)  Phase I Study of Delivery of Autologous Bone Marrow Derived Mononuclear Cells to Myopathic Right Ventricle in Patients with Ebstein Anomaly During Surgical Intervention.  This trial will deliver bone marrow-derived cells into the hearts of patients with Ebstein anomaly (EA), a malformed heart valve that doesn't properly close.
  • Dr. Nathan P. Staff, MD, PhD   (Clinical Trial Grant)  A Phase IIA Study Using Intrathecal Treatment of Autologous Adipose-Derived Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.  Clinical trial will assess safety and efficacy of mesenchymal stem cell spinal injections as a regenerative therapy for amyotrophic lateral sclerosis (ALS), an incurable condition that gradually degenerates nerve cells and reduces voluntary muscle function.

Tags: Uncategorized

Please sign in or register to post a reply.
Contact Us · Privacy Policy